BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 28602108)

  • 1. Pharmacotherapy for community-acquired pneumonia in the elderly.
    Viasus D; Núñez-Ramos JA; Viloria SA; Carratalà J
    Expert Opin Pharmacother; 2017 Jul; 18(10):957-964. PubMed ID: 28602108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-acquired pneumonia in the elderly.
    Torres A; El-Ebiary M; Riquelme R; Ruiz M; Celis R
    Semin Respir Infect; 1999 Jun; 14(2):173-83. PubMed ID: 10391411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic.
    File TM; Monte SV; Schentag JJ; Paladino JA; Klugman KP; Lavin B; Yu VL; Singer ME; Adelman MH
    Int J Antimicrob Agents; 2009 Jan; 33(1):58-64. PubMed ID: 18835762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study.
    Iroezindu MO; Chima EI; Isiguzo GC; Mbata GC; Onyedum CC; Onyedibe KI; Okoli LE
    Scand J Infect Dis; 2014 Dec; 46(12):875-87. PubMed ID: 25288384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of beta-lactam agents in the treatment of community-acquired pneumonia.
    Garau J
    Eur J Clin Microbiol Infect Dis; 2005 Feb; 24(2):83-99. PubMed ID: 15696306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae.
    Yayan J
    Drug Des Devel Ther; 2014; 8():1733-43. PubMed ID: 25336917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-acquired pneumonia.
    Cassiere HA; Niederman MS
    Dis Mon; 1998 Nov; 44(11):613-75. PubMed ID: 9858958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guideline 'Diagnosis and treatment of community-acquired pneumonia' from the Dutch Thoracic Society].
    Aleva RM; Boersma WG;
    Ned Tijdschr Geneeskd; 2005 Nov; 149(45):2501-7. PubMed ID: 16304887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options for community-acquired pneumonia in the elderly people.
    Petrosillo N; Cataldo MA; Pea F
    Expert Rev Anti Infect Ther; 2015 Apr; 13(4):473-85. PubMed ID: 25746632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillin resistance in pneumococcal pneumonia. Antibiotics with low resistance potential are effective and pose less risk.
    Cunha BA
    Postgrad Med; 2003 Jan; 113(1):42-4, 47-8, 52-4. PubMed ID: 12545592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics-pharmacodynamics of quinolones against Streptococcus pneumoniae in patients with community-acquired pneumonia.
    Bhavnani SM; Forrest A; Hammel JP; Drusano GL; Rubino CM; Ambrose PG
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):99-101. PubMed ID: 18583085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic stewardship in community-acquired pneumonia.
    Viasus D; Vecino-Moreno M; De La Hoz JM; Carratalà J
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):351-359. PubMed ID: 28002979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New trends in the prevention and management of community-acquired pneumonia.
    Postma DF; van Werkhoven CH; Huijts SM; Bolkenbaas M; Oosterheert JJ; Bonten MJ
    Neth J Med; 2012 Oct; 70(8):337-48. PubMed ID: 23065981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing community acquired pneumonia in the elderly - the next generation of pharmacotherapy on the horizon.
    Amalakuhan B; Echevarria KL; Restrepo MI
    Expert Opin Pharmacother; 2017 Aug; 18(11):1039-1048. PubMed ID: 28598693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of community acquired pneumonia].
    Welte T
    Internist (Berl); 2007 May; 48(5):476, 478-80, 482-4 passim. PubMed ID: 17431572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New quinolones for the treatment of community-acquired pneumonia--contra].
    Egger M
    Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860
    [No Abstract]   [Full Text] [Related]  

  • 17. Community acquired bacterial pneumonia.
    Anevlavis S; Bouros D
    Expert Opin Pharmacother; 2010 Feb; 11(3):361-74. PubMed ID: 20085502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of community-acquired pneumonia in hospitalised patients.
    Mulazimoglu L
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S63-70. PubMed ID: 11574198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].
    Roger PM; Risso K; Hyvernat H; Landraud L; Vassallo M; Dellamonica J; de Salvador F; Cua E; Bernardin G
    Med Mal Infect; 2010 Jun; 40(6):347-51. PubMed ID: 20172672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review.
    Torres A; Blasi F; Peetermans WE; Viegi G; Welte T
    Eur J Clin Microbiol Infect Dis; 2014 Jul; 33(7):1065-79. PubMed ID: 24532008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.